Home » Innovation » Valorisation Committee

Valorisation Committee

Évaluer et sélectionner les projets

A dedicated valorisation committee

Immun4Cure has a dedicated valorisation committee composed of founding members and partners, whose mission is to evaluate and select projects from research teams within the institute perimeter that will be submitted for early-stage funding to the Montpellier University Innovation Cluster (PUI) and for further development to the SATT AxLR. This committee will also be able to issue an opinion on the most appropriate commercialisation route, i.e. the creation of start-ups or the transfer of operating licences to an existing company.

Projects receiving early-stage/maturation funding will be presented by SATT AxLR, as a member of the consortium, to the Combio National Acceleration Strategy (SNA) dedicated to biotherapies and the bioproduction of innovative therapies, which aims to make France the leading European country for the development and production of new biomedicines.

The early-stage and maturity funding provided by SATT AXLR and SNA Combio will enable preclinical phases to be accelerated, allowing clinical phases to be reached more quickly. With around ten biotech start-ups already created, we anticipate that, thanks to the IHU, there will be an increase in the number of companies created that will bring the solutions developed in Montpellier to market. Thus, in addition to being an accelerator for therapeutic solutions, the IHU Immun4cure will have an impact on the economic development of the region.

Philippe Nérin,

Chairman of SATT AxLR